These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1052 related items for PubMed ID: 18068306

  • 1. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K.
    Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
    [Abstract] [Full Text] [Related]

  • 2. Relationships of DEX/CRH and GHRH test results to the outcome of depression--preliminary results suggest the GHRH test may predict relapse after discharge.
    Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K.
    J Psychiatr Res; 2008 Apr; 42(5):356-64. PubMed ID: 17412362
    [Abstract] [Full Text] [Related]

  • 3. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
    Ising M, Horstmann S, Kloiber S, Lucae S, Binder EB, Kern N, Künzel HE, Pfennig A, Uhr M, Holsboer F.
    Biol Psychiatry; 2007 Jul 01; 62(1):47-54. PubMed ID: 17123470
    [Abstract] [Full Text] [Related]

  • 4. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F.
    Psychoneuroendocrinology; 2009 Jan 01; 34(1):99-109. PubMed ID: 18829172
    [Abstract] [Full Text] [Related]

  • 5. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A, Brunner H, Ising M, Pedrosa Gil F, Holsboer F, Friess E.
    Psychoneuroendocrinology; 2004 Oct 01; 29(9):1101-8. PubMed ID: 15219633
    [Abstract] [Full Text] [Related]

  • 6. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.
    Lammers CH, Garcia-Borreguero D, Schmider J, Gotthardt U, Dettling M, Holsboer F, Heuser IJ.
    Biol Psychiatry; 1995 Dec 15; 38(12):803-7. PubMed ID: 8750038
    [Abstract] [Full Text] [Related]

  • 7. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C, Vermetten E, Lentjes E, Geuze E, van Pelt J, Manuel R, Heijnen C, Westenberg H.
    Psychoneuroendocrinology; 2008 Apr 15; 33(3):313-20. PubMed ID: 18215470
    [Abstract] [Full Text] [Related]

  • 8. Plasma corticosterone, dexamethasone (DEX) suppression and DEX/CRH tests in a rat model of genetic vulnerability to depression.
    Steimer T, Python A, Schulz PE, Aubry JM.
    Psychoneuroendocrinology; 2007 Jun 15; 32(5):575-9. PubMed ID: 17512120
    [Abstract] [Full Text] [Related]

  • 9. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study.
    Kunugi H, Ida I, Owashi T, Kimura M, Inoue Y, Nakagawa S, Yabana T, Urushibara T, Kanai R, Aihara M, Yuuki N, Otsubo T, Oshima A, Kudo K, Inoue T, Kitaichi Y, Shirakawa O, Isogawa K, Nagayama H, Kamijima K, Nanko S, Kanba S, Higuchi T, Mikuni M.
    Neuropsychopharmacology; 2006 Jan 15; 31(1):212-20. PubMed ID: 16123748
    [Abstract] [Full Text] [Related]

  • 10. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E, Schmid D, Modell S, Brunner H, Lauer CJ, Holsboer F, Ising M.
    J Psychiatr Res; 2008 Oct 15; 42(14):1154-62. PubMed ID: 18281062
    [Abstract] [Full Text] [Related]

  • 11. Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I.
    Schmider J, Lammers CH, Gotthardt U, Dettling M, Holsboer F, Heuser IJ.
    Biol Psychiatry; 1995 Dec 15; 38(12):797-802. PubMed ID: 8750037
    [Abstract] [Full Text] [Related]

  • 12. Hormonal differences between psychotic and non-psychotic melancholic depression.
    Contreras F, Menchon JM, Urretavizcaya M, Navarro MA, Vallejo J, Parker G.
    J Affect Disord; 2007 Jun 15; 100(1-3):65-73. PubMed ID: 17098292
    [Abstract] [Full Text] [Related]

  • 13. Changes in the hypothalamic-pituitary-adrenal axis and leptin levels during antidepressant treatment.
    Himmerich H, Zimmermann P, Ising M, Kloiber S, Lucae S, Kunzel HE, Binder EB, Holsboer F, Uhr M.
    Neuropsychobiology; 2007 Jun 15; 55(1):28-35. PubMed ID: 17556850
    [Abstract] [Full Text] [Related]

  • 14. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
    Connan F, Lightman SL, Landau S, Wheeler M, Treasure J, Campbell IC.
    J Psychiatr Res; 2007 Jun 15; 41(1-2):131-43. PubMed ID: 16455105
    [Abstract] [Full Text] [Related]

  • 15. Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression).
    Appelhof BC, Huyser J, Verweij M, Brouwer JP, van Dyck R, Fliers E, Hoogendijk WJ, Tijssen JG, Wiersinga WM, Schene AH.
    Biol Psychiatry; 2006 Apr 15; 59(8):696-701. PubMed ID: 16368077
    [Abstract] [Full Text] [Related]

  • 16. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE, Ackl N, Hatzinger M, Held K, Holsboer-Trachsler E, Ising M, Kaschka W, Kasper S, Konstantinidis A, Sonntag A, Uhr M, Yassouridis A, Holsboer F, Steiger A.
    J Psychiatr Res; 2009 Apr 15; 43(7):702-10. PubMed ID: 19038406
    [Abstract] [Full Text] [Related]

  • 17. Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis.
    Grasser A, Möller A, Backmund H, Yassouridis A, Holsboer F.
    Exp Clin Endocrinol Diabetes; 1996 Apr 15; 104(1):31-7. PubMed ID: 8750568
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
    Künzel HE, Binder EB, Nickel T, Ising M, Fuchs B, Majer M, Pfennig A, Ernst G, Kern N, Schmid DA, Uhr M, Holsboer F, Modell S.
    Neuropsychopharmacology; 2003 Dec 15; 28(12):2169-78. PubMed ID: 12931142
    [Abstract] [Full Text] [Related]

  • 19. Persistent cognitive impairment in depression: the role of psychopathology and altered hypothalamic-pituitary-adrenocortical (HPA) system regulation.
    Reppermund S, Zihl J, Lucae S, Horstmann S, Kloiber S, Holsboer F, Ising M.
    Biol Psychiatry; 2007 Sep 01; 62(5):400-6. PubMed ID: 17188252
    [Abstract] [Full Text] [Related]

  • 20. A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD--first preliminary results.
    Muhtz C, Wester M, Yassouridis A, Wiedemann K, Kellner M.
    J Psychiatr Res; 2008 Jul 01; 42(8):689-93. PubMed ID: 17884095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.